eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
Published 1 year ago • 98 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
1:51
eleanor interim analysis: real-world study of adjuvant neratinib in her2 /hr early breast cancer
-
2:34
eleanor: real-world use of neratinib in her2 , early breast cancer
-
2:46
eleanor: observing real-life extended adjuvant therapy with neratinib and concurrent use of conkado
-
6:47
extended adjuvant therapy for her2-positive early breast cancer
-
8:21
extended adjuvant therapy for her2-positive breast cancer
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
8:44
reduce the risk of recurrence in early stage her2 breast cancer
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
1:37
dr. traina on conversations on extended adjuvant therapy with neratinib in her2 breast cancer
-
2:59
talent: neoadjuvant t-dxd with or without anastrozole for her2-low, hr early stage breast cancer
-
2:48
the extenet study & management of her2 breast cancer
-
2:51
breast cancer: extended adjuvant therapy and cost factors
-
1:38
dr. shao on managing toxicity with neratinib in her2 breast cancer
-
2:00
neratinib after trastuzumab-based adjuvant therapy in her 2 positive breast cancer (extenet)
-
3:25
role for neratinib following adjuvant dual-targeted her2 therapy
-
0:52
dr. gradishar on the role of neratinib in the treatment of her2 breast cancer
-
9:35
neratinib in her2 breast cancer
-
7:23
extended adjuvant therapy in her2-positive disease
-
4:56
erin b takes a stand against early-stage her2 breast cancer recurrence with nerlynx
-
2:18
use of neratinib in her2-positive breast cancer
-
5:24
the extenet trial